Clinical Trial Update: Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tolerability and efficacy of adding midostaurin to a 10-day decitabine regimen in unfit adults with acute myeloid leukemia and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)
• Midostaurin (midostaurin)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: AML/MDS | Phase 2 | Status: ACTIVE_NOT_RECRUITING